High turbulence liquid chromatography online extraction and tandem mass spectrometry for the simultaneous determination of suberoylanilide hydroxamic acid and its two metabolites in human serum
- 8 June 2005
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 19 (13) , 1779-1787
- https://doi.org/10.1002/rcm.1984
Abstract
A reliable and sensitive method incorporating high turbulence liquid chromatography (HTLC) online extraction with tandem mass spectrometry (MS/MS), for simultaneous determination of suberoylanilide hydroxamic acid (SAHA) and its two metabolites, SAHA‐glucuronide (M1) and 4‐anilino‐4‐oxobutanoic acid (M2), in human serum, has been developed to support clinical studies. The HTLC technology significantly reduces the time required for sample clean‐up since sample extraction and analysis are performed online. Clinical samples, internal standards (IS) and buffer are transferred into 96‐well plates using a robotic liquid handling system. A 20 µL aliquot of prepared sample is directly injected into the HTLC/LC‐MS/MS system where the matrix is rapidly washed away to waste and the analytes are retained on the narrow‐bore extraction column (0.5 × 50 mm), using an aqueous mobile phase at 1.5 mL/min. Analytes are then eluted from the extraction column and transferred to the analytical column using a gradient mobile phase prior to detection by MS/MS. Interference with determination of SAHA from in‐source dissociation of M1 is eliminated by the chromatographic separation. The resolution of SAHA and M1 did not change for more than 1500 serum sample injections by applying an acid wash (15% acetic acid) on the extraction column. The linear calibration ranges for SAHA, M1, and M2 are 2–500, 5–2000, and 10–2000 ng/mL, respectively. Assay intraday validation was conducted using five calibration curves prepared in five lots of human control serum. The precision expressed as relative standard deviation (RSD) is less than 6.8% and accuracy is 94.6–102.9% of nominal values for all three analytes. Assay specificity, freeze/thaw stability, storage stability, and matrix effects were also assessed. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- High-throughput liquid chromatography for drug analysis in biological fluids: investigation of extraction column lifeJournal of Chromatography B, 2004
- Histone deacetylase inhibitors in clinical developmentExpert Opinion on Investigational Drugs, 2004
- A direct injection high‐throughput liquid chromatography tandem mass spectrometry method for the determination of a new orally active αvβ3 antagonist in human urine and dialysateRapid Communications in Mass Spectrometry, 2003
- Histone deacetylasesCurrent Opinion in Pharmacology, 2003
- Histone deacetylase inhibitors: from target to clinical trialsExpert Opinion on Investigational Drugs, 2002
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Interference of a carbamoyl glucuronide metabolite in quantitative liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2001
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- The use of high-flow high performance liquid chromatography coupled with positive and negative ion electrospray tandem mass spectrometry for quantitative bioanalysis via direct injection of the plasma/serum samplesRapid Communications in Mass Spectrometry, 1998
- Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and functionBioEssays, 1995